<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The 2008 WHO classification tentatively introduced <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> with <z:mp ids='MP_0003045'>fibrosis</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-F) based on previous literature of the existence of such cases </plain></SENT>
<SENT sid="1" pm="."><plain>Most <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-F cases have increased blasts, lower <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> and platelet counts, an aggressive clinical course, and more frequently include cytogenetic aberrations </plain></SENT>
<SENT sid="2" pm="."><plain>We report the case of a 66-year-old male patient diagnosed with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts-2 with <z:mp ids='MP_0003045'>fibrosis</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> <z:e sem="disease" ids="C1318551" disease_type="Neoplastic Process" abbrv="">RAEB-2</z:e>-F) with a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype and negative findings for both BCR-ABL1 transcript and JAK2 V617F mutations </plain></SENT>
<SENT sid="3" pm="."><plain>He refused therapy upon his diagnosis and, after 5 months, his disease progressed to <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The patient was diagnosed with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>-related changes (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-MRC), based on a bone marrow exam revealing increased blasts (32.8%) </plain></SENT>
<SENT sid="5" pm="."><plain>Cytogenetic study revealed a complex karyotype, and molecular studies identified a minor BCRABL1 fusion transcript </plain></SENT>
<SENT sid="6" pm="."><plain>The patient's general condition deteriorated despite the initiation of induction chemotherapy, and he died approximately 2 weeks after the diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-MRC </plain></SENT>
<SENT sid="7" pm="."><plain>This patient's poor clinical outcome may have been exacerbated by the acquisition of the BCR-ABL1 fusion transcript overlapping with the aggressive nature of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-F </plain></SENT>
</text></document>